Spiro Rombotis

Cyclacel Pharmaceuticals, Inc., President & CEO

Spiro Rombotis, President and Chief Executive Officer of Cyclacel Pharmaceuticals, Inc. (Berkeley Heights, NJ and Dundee, Scotland), joined the company in August 1997 as the founding CEO.  He has over 27 years of experience with pharmaceutical and biotechnology companies.  

Mr. Rombotis was previously Vice President of International Operations and Business Development; Managing Director, Europe; and Director, Japanese Joint Venture, at The Liposome Company, Inc., a NASDAQ-listed biotechnology company subsequently acquired by Elan Corp.  Mr. Rombotis also served as Vice President of Pharmaceuticals for Central and Eastern Europe and as Director of International Marketing at Bristol-Myers Squibb Company.  He was one of the first employees of Centocor, Inc., and served as Head of European Marketing and Sales and Head of Corporate Development.  He began his career in pharmaceuticals in Switzerland at the business development group of Ciba-Geigy AG, subsequently Novartis AG.